Mauro Buttarello1. 1. Servizio di Medicina di Laboratorio, Azienda Ospedaliera, via Giustiniani 2, 35128, Padova, Italy. mbuttarello@yahoo.it
Abstract
BACKGROUND: Quality specifications for automated blood cell counts include topics that go beyond the traditional analytic stage (imprecision, inaccuracy, quality control) and extend to pre- and post-analytic phases. METHODS: In this review pre-analytic aspects concerning the choice of anticoagulants, maximum conservation times and differences between storage at room temperature or at 4 degrees C are considered. For the analytic phase, goals for imprecision and bias obtained with various approaches (ratio to biologic variation, state of the art, specific clinical situations) are evaluated. For the post-analytic phase, medical review criteria (algorithm, decision limit and delta check) and the structure of the report (general part and comments), which constitutes the formal act through which a laboratory communicates with clinicians, are considered. RESULTS: K2EDTA is considered the anticoagulant of choice for automated cell counts. Regarding storage, specimens should be analyzed as soon as possible. Storage at 4 degrees C may stabilize specimens from 24 to 72 h when complete blood count (CBC) and differential leucocyte count (DLC) is performed. For precision, analytical goals based on the state of the art are acceptable while for bias this is satisfactory only for some parameters. CONCLUSIONS: In haematology quality specifications for pre- and analytical phases are important, but the review criteria and the quality of the report play a central role in assuring a definite clinical value.
BACKGROUND: Quality specifications for automated blood cell counts include topics that go beyond the traditional analytic stage (imprecision, inaccuracy, quality control) and extend to pre- and post-analytic phases. METHODS: In this review pre-analytic aspects concerning the choice of anticoagulants, maximum conservation times and differences between storage at room temperature or at 4 degrees C are considered. For the analytic phase, goals for imprecision and bias obtained with various approaches (ratio to biologic variation, state of the art, specific clinical situations) are evaluated. For the post-analytic phase, medical review criteria (algorithm, decision limit and delta check) and the structure of the report (general part and comments), which constitutes the formal act through which a laboratory communicates with clinicians, are considered. RESULTS:K2EDTA is considered the anticoagulant of choice for automated cell counts. Regarding storage, specimens should be analyzed as soon as possible. Storage at 4 degrees C may stabilize specimens from 24 to 72 h when complete blood count (CBC) and differential leucocyte count (DLC) is performed. For precision, analytical goals based on the state of the art are acceptable while for bias this is satisfactory only for some parameters. CONCLUSIONS: In haematology quality specifications for pre- and analytical phases are important, but the review criteria and the quality of the report play a central role in assuring a definite clinical value.
Authors: Benjamin A von Schweinitz; Robert A De Lorenzo; Peter J Cuenca; Richard L Anschutz; Paul B Allen Journal: Intern Emerg Med Date: 2014-10-17 Impact factor: 3.397
Authors: Mohamed M Abdel-Daim; Abdelrahman Ibrahim Abushouk; Maha I Alkhalf; Eman A Toraih; Manal S Fawzy; Hira Ijaz; Lotfi Aleya; Simona G Bungau Journal: Environ Sci Pollut Res Int Date: 2018-07-25 Impact factor: 4.223
Authors: Labrini Vasileiou Athanasiou; Zoe Polizopoulou; Maria Rafaela Kalafati; George Ntararas; Vasileios Kontos Journal: Vet Res Forum Date: 2016-12-15 Impact factor: 1.054
Authors: Sant-Rayn Pasricha; Varalaxmi Vijaykumar; N S Prashanth; H Sudarshan; Beverley-Ann Biggs; Jim Black; Arun Shet Journal: BMC Public Health Date: 2009-02-17 Impact factor: 3.295